Muse

SYMHC Classics: Penicillin
Stuff You Missed in History Class

SYMHC Classics: Penicillin

from Stuff You Missed in History Class

July 11, 2026 | 00:42:45 | History, Society & Culture

0 0
0.0 (0)
8
0 0
This 2022 episode covers the development of penicillin, which started – but definitely did not end – with the chance discovery of some mold in a petri dish. See omnystudio.com/listener for privacy information.
0:00 / 0:00
1.0× 100%


Transcript

00:00:00 - 00:01:38 | Speaker 3:

This is an iHeart Podcast. Guaranteed human. Living with a rare autoimmune condition brings uncertainty, but it can also create community. In season six of Untold Stories, Life with a Severe Autoimmune Condition, they go beyond MG and CIDP, as host Martine Hackett welcomes stories from other conditions like myositis and IGAN into the conversation. Untold Stories is produced by Ruby Studio in partnership with Argenix. Listen to Untold Stories, Life with a Severe Autoimmune Condition, on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts. Hey everybody, we are getting ready to go on a trip. We're not packed yet, but our brains definitely are because we have a trip to Baja Mar on the horizon and it's kind of all I can think about. I'm so excited about the food. There are amazing restaurants and lounges there that I'm gonna sample everything I possibly can. I'm gonna gaze into the water and mostly I am gonna watch the Daily Flamingo Parade, which might be the thing I'm most excited about. There's also an incredible spa, and I know Tracy's going to be taking advantage of that. There is excited, and then there is Bahamar excited. Start planning at bahamar.com. Alienware's back-to-school event is the perfect time to score top gaming gear with incredible features and advanced engineering to go beyond performance. Start your Alienware journey with the Alienware 15 gaming laptop featuring Intel Core processors. Game, live stream, and multitask for hours on end. Pair your incredibly smooth gaming experience with immersive visuals and sound by saving on sleek Alienware monitors, headsets, and more. This limited-time sale awaits you now at Alienware.com slash deals.

00:01:41 - 00:01:57 | Speaker 1:

Snoring, gasping for air during sleep, daytime sleepiness? I'm Shaquille O'Neal, and this shouldn't be anybody's experience. Ask your doctor about ZepBound Trisepatide, the first and only FDA-approved prescription medicine for moderate to severe obstructive sleep apnea in adults with obesity.

00:01:57 - 00:03:04 | Speaker 2:

ZepBound is a prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with moderate to severe obstructive sleep apnea, OSA, and obesity to improve their OSA. ZepBound is approved as a 2.5, 5, 7.5, 10, 12.5, or 15 milligram injection. ZepBound contains trisepatide and should not be used with other trisepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if ZepBound is safe and effective for use in children. Don't share needles or pens or reuse needles. Don't take if allergic to it, or if you or someone in your family had medullary thyroid cancer, or if you've had multiple endocrine neoplasia syndrome type 2. Tell your doctor if you get a lump or swelling in your neck. Stop ZepBound and call your doctor if you have severe stomach pain or a serious allergic reaction. Severe side effects may include inflamed pancreas or gallbladder problems. Tell your doctor if you experience vision changes before scheduled procedures with anesthesia. If you're nursing, pregnant, plan-to-be, or taking birth control pills, taking ZepBound with a sulfonylurea or insulin may cause low blood sugar. Side effects include nausea, diarrhea, and vomiting, which can cause dehydration and worsen kidney problems.

00:03:05 - 00:03:11 | Speaker 1:

Talk to your doctor. Call 1-800-545-5979 or visit ZepBound.lily.com.

00:03:13 - 00:05:00 | Speaker 3:

Happy Saturday. After this week's episodes on Dorothy Crowfoot Hodgkin, including her work determining the structure of penicillin, today's Saturday classic is on the discovery of penicillin. This episode originally came out on September 5th, 2022. Enjoy! Welcome to Stuff You Missed in History Class, a production of iHeartRadio. Hello, and welcome to the podcast. I'm Tracy V. Wilson. And I'm Holly Frey. Holly, when you were a kid, did you learn the story of penicillin? I feel like I didn't get it until later. Okay. Do you remember what you learned? You know, accidental grew on mold because there was a rumor at our school that you could make your own antibiotics in your bedroom. Well, we'll talk about something similar to that. And you better believe my crafty little brain was like, could I? Could I start a little apothecary out of my closet? Maybe. So I, like a lot of people, learned this very basic story about Alexander Fleming leaving a Petri dish out and it getting contaminated with mold. And then it's just sort of presented as voila, penicillin. He did it all by himself. that is not remotely accurate. Like, the Petri dish and mold part, that part, kind of accurate. At least we'll talk more about it. But, like, it was not suddenly he had invented penicillin by himself at all. So that's one of the things we're going to talk about.

00:05:00 - 00:05:38 | Speaker 1:

Also, though, this was just inspired by an email from listener Abby, which we actually read on the show recently. And Abby mentioned that after World War II, there was a penicillin recycling project. And I was like, I need to know more about this. And I didn't talk about it a lot in that listener mail segment because it is gross. So, just as a heads up, there is a lot of mold in this episode, and if a phrase like mold broth bothers you, maybe this is not the episode for you.

00:05:38 - 00:05:40 | Speaker 2:

That's your punk band, mold broth.

00:05:40 - 00:05:54 | Speaker 1:

Yeah, mold broth. We're also just, there's a lot of bodily fluids, there's also some animal testing, just, you know, I know people can be squeamish about particular things, just a heads up on all of that.

00:05:54 - 00:06:20 | Speaker 2:

So, like we just said, the development of penicillin started, but definitely did not end, with the chance discovery of some mold in a Petri dish. We're going to get back to that, but the discovery of a seemingly miraculous treatment made from mold piqued the interest of medical historians who started looking for earlier uses of mold as a treatment for wounds or diseases. And it turned out there were actually a lot of them.

00:06:20 - 00:07:25 | Speaker 1:

Yeah, the people who had been using these obviously already knew about them, but there had not really been a systemic historical look at it. The vast majority of these treatments involved using mold to make a topical preparation for wounds. So this included using moldy soybeans in China and moldy bread in Egypt and cheese mold in Greece, with all of those dating back roughly 3,000 years or more. Aboriginal and indigenous peoples all around the world have used molds medicinally as well. There's also some evidence that more than 2,000 years ago, people in northern Africa consumed something that contained enough tetracycline to leave evidence of that on their bones. Tetracycline actually comes from bacteria, not from mold, but the bacteria in question form these branching filaments that look enough like a fungus that it was classified as a fungus for a really long time. In more recent times, herbalists and apothecaries

00:07:25 - 00:08:02 | Speaker 2:

in Europe described medicinal mold preparations all through the 17th and 18th centuries. And researchers looking into the historical use of mold in the 20th century found that a lot of folk remedies using mold were still around. One biochemist described traveling through Europe and finding that each home had a moldy loaf of bread stored in the kitchen rafters, which would be used to prepare dressings for cuts or other wounds. Other oral accounts described people intentionally growing mold on oranges or other fruit or substances or collecting it from meat as it was being cured.

00:08:02 - 00:08:39 | Speaker 1:

We don't really have a lot of detail about how effective these treatments actually were. There weren't clinical studies or things like that to reference, But there are so many different medicinal uses for molds to treat infections in so many different parts of the world that some medical historians have concluded that at least some of them probably did have some real antimicrobial efficacy. Some of the folks that were interviewed about their folk remedies after penicillin was developed and they learned that penicillin was made out of mold, they were kind of like, oh, yeah, we've been doing that forever. And?

00:08:40 - 00:09:03 | Speaker 2:

By the time Fleming spotted that contaminated culture plate, it was already established that various bacteria, molds, and other organisms could inhibit one another's growth. The term antibiosis was coined by the end of the 19th century to describe this antagonistic effect that microorganisms could have on one another. And there may have even been some work with

00:09:03 - 00:10:00 | Speaker 1:

penicillium mold specifically before Fleming made his discovery. Joseph Lister may have successfully treated a patient with a filtrate made from penicillium glaucum as early as 1877. Around the same time, there were other doctors and scientists experimenting with whether penicillium mold killed other microorganisms in a lab. None of this is totally certain though. The taxonomy for molds and other fungi was not very robust yet, and the people who were doing this work were not experts in mycology. It's possible that they were working with totally different molds that they were just calling penicillium. And then aside from that, none of them published a thorough description of their work. So a lot of this conclusion is based on notes, which were not necessarily complete. You cannot replicate an experiment to test it. if you

00:10:00 - 00:10:39 | Speaker 2:

don't really know what went down. The early 20th century saw the development of the first drugs that killed specific bacteria. In the 1870s, German physician Paul Ehrlich had noticed that chemical dyes changed the color of some bacteria and not others. This was a precursor to the gram staining method that is still used today to broadly classify bacteria as gram positive and gram negative based on how they respond to the stain. Ehrlich started to wonder if it was also possible to discover a substance that killed some bacteria but not others. In 1909, researchers in Ehrlich's

00:10:39 - 00:11:21 | Speaker 1:

lab discovered that the arsenic compound arsphenamine killed the bacteria that cause syphilis. This drug was marketed as salivarsan and it was also known as 606 because it was the 606th preparation that had been tested in Ehrlich's lab as part of this project. Salversan was found to be effective against other infectious diseases as well. This was really the first effective treatment for syphilis and the first modern antimicrobial compound. Ehrlich described this use of a chemical to kill cells in the body using the word chemotherapy, and he coined the term magic bullet to describe the drug's ability to target pathogens.

00:11:21 - 00:12:12 | Speaker 2:

Ehrlich's lab had been systematically testing one arsenic compound after another when it developed Salverson. On the other hand, Alexander Fleming's discovery of penicillin a little less than 20 years later was an accident. He was interested in the antimicrobial properties of the body's own fluids and secretions. He coined the term lysozyme to describe a substance in things like mucus, tears, and saliva that seemed to inhibit bacterial growth. He reportedly made this discovery when he had a cold. He cultured his own mucus in a Petri dish and then later discovered that the area around the mucus wasn't growing bacteria. In some versions of this story, his office was perpetually untidy, and this Petri dish had sat there forgotten and some clutter for a couple of weeks before he made the discovery.

00:12:12 - 00:12:46 | Speaker 1:

His discovery of penicillin had some similarities. This time, he was studying staph bacteria, and all of his petri dishes were supposed to be in an incubator when he left for a two-week vacation in 1928. One of them, though, was apparently left on a lab bench by accident. When he got back to the office on September 3rd, he noticed the misplaced petri dish that had been contaminated with mold, and the area around the mold, he saw colonies of staph bacteria that were dying.

00:12:47 - 00:13:11 | Speaker 2:

We don't know exactly where the mold contamination came from. One possibility is an open window, and another is a mycology lab that was in the same building. And this discovery was only possible because the Petri dish was left out on a bench. If it had gone into the incubator like it was supposed to, the staph bacteria would have flourished, but the temperature would have been wrong for the mold to grow.

00:13:12 - 00:13:58 | Speaker 1:

Beyond this, other details are really hazy. Fleming did not take careful notes about exactly what he was looking at when either he or one of his assistants spotted this petri dish. His later descriptions about exactly how the mold and the bacteria were interacting with one another could be contradictory. When he published his discovery in the British Journal of Experimental Pathology in June of 1929, he made it sound as though he routinely left his staff culture on plates on the bench for extended periods, rather than that often repeated story that this was one that was forgotten while he was on vacation. He also described the mold as most resembling penicillium rubrum, and other researchers later corrected that

00:13:58 - 00:14:37 | Speaker 2:

identification to penicillium notatum. That June 1929 paper describes various experiments Fleming and his colleagues did with a filtrate made from the broth the mold was growing in. He coined the term penicillin to describe this filtrate because writing, quote, mold broth filtrate over and over was apparently cumbersome. He did some basic toxicity tests in small mammals by injecting them with this filtrate, and it did not seem to be toxic. But he doesn't seem to have tried injecting animals with one of the bacteria that he knew penicillin killed in a Petri dish to see if that worked in a living body as well.

00:14:38 - 00:15:31 | Speaker 1:

He did test penicillin's activity against various microbes in a Petri dish, including Staphylococcus, Streptococcus, and Pneumococcus, as well as what was described at the time as Bacillus influenzae and Bacillus diphtheriae. Penicillin was particularly effective against all the pyogenic cocci. the ones that ended with caucus in that list, but it wasn't as effective against the bacilli. So if he had a petri dish that was growing both staph bacteria and bacillus influenzae, he could use penicillin to kill only the staph, leaving that bacillus culture in place. Side note, today bacillus influenzae is known as hemophilus influenzae. It got the influenzae moniker when people thought that it caused influenza, which it does not. Influenza is

00:15:31 - 00:15:37 | Speaker 2:

caused by a virus. Just to keep things a little confusing for everybody. That was one of the

00:15:37 - 00:15:41 | Speaker 1:

things about reading this paper was then needing to go and look like, what do they call that now?

00:15:41 - 00:16:09 | Speaker 2:

I don't think that's what they call that now. Fleming didn't really have the skills or expertise to try to extract this filtrate into a usable medicine. His research students, Stuart Craddock and Frederick Ridley both worked on this, and both of them were credited at the end of the published paper. Fleming also sent samples of the mold to anyone who asked for it. But he didn't really make any headway into turning penicillin into a medicine, and he stopped working with it

00:16:09 - 00:16:15 | Speaker 1:

in 1931. We'll talk about how it did become a medicine after a sponsor break.

00:16:15 - 00:18:33 | Speaker 2:

living with a rare autoimmune condition can bring a lot of uncertainty but it can also bring people together in powerful ways tune in for season six of untold stories life with a severe autoimmune condition a ruby studio production in partnership with argenics this season host martine hackett brings you fresh stories from people living with mg and cidp and expands the conversation to people living with other rare conditions like myositis and IGAM. Through their stories, you'll learn what it's like to participate in clinical trials seeking new treatments, how connection fuels hope, and how people can support one another along the way. Because living with a rare disease isn't about getting through it, it's about moving forward together. Listen to Untold Stories, Life with a Severe Autoimmune Condition on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts. all righty there is excited and then there is vacation excited and we are vacation excited right now because we have a trip planned to Baja Mar in Nassau to be honest I'm kind of mentally already checked in and I have a beautiful drink in my hand what I love about this is that you can do it your way there are three luxury hotels all in one place the refined rosewood the playfully hip SLS or the stylish Grand Hyatt. So no matter what your vibe is, if it's relaxed, if it's glam, if it's kind of somewhere in between, you're covered. And then there is everything else. This is like an embarrassment of options. There are more than 45 restaurants, bars and lounges, incredible chefs, incredible drinks. I'm going to be all over that. There is a lot of great nightlife that you can get into, like the John Baptiste Jazz Club, which I am also very excited about. If you are a family going to visit, there's a 15 acre water park. And what I'm also excited about, shark and sea turtle encounters. Bring them on and don't even get me started about the Daily Flamingo Parade. If you're into sporty stuff, all there. There is a golf course, tennis, pickleball, anything you can think of. Tracy's going to spend a lot of time at the spa and we are going to spend a lot of time enjoying ourselves. There's excited and then there is Baja Mar vacation excited. Start planning your perfect getaway at BajaMar.com.

00:18:35 - 00:19:40 | Speaker 1:

So, you're considering getting a home security system, but you want something that fits your space. Well, with ADT Blue, it's easy to customize a system that's right for you and set it up yourself. Just pick the kit and monitoring plan that makes sense for your home. Let's say you're worried about package theft. The ADT Plus app can walk you through setting up a new doorbell camera kit. Once it's installed, ADT Pros can help you keep tabs on it 24-7, or you can manage it yourself from the ADT Plus app. There are no long-term contracts, so you can change your monitoring plan whenever you want. The flexibility doesn't end there. You can add to your system as you need to with things like extra cameras or motion sensors. Some life decisions are hard, but thanks to ADT Blue, you can DIY trusted ADT home security in a snap. Head to ADT.com slash BLU to build your system today. And to hear more about home protection and other grown-up topics, check out new episodes of Grown-Up Stuff on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts.

00:19:44 - 00:20:43 | Speaker 2:

We've all done it. Tumble down an internet rabbit hole trying to self-diagnose. And sometimes doing our own research can leave us more anxious than informed. Your feed is packed with wellness trends telling you to cold plunge, protein max, detox. Track your sleep, but what's actually real? What's exaggerated? What's just wrong? That's exactly what Health vs. Hype from the American Medical Association and iHeartMedia's Ruby Studio is here to find out. Each episode, Emmy-nominated science communicator Trace Dominguez, who's racked up billions of views across PBS, Discovery Channel, and YouTube, talks to doctors, influencers, and real people trying these trends. Not to cancel them, not to hype them more, but to actually understand them. Because when it comes to your health, who you listen to matters. Start asking better questions and listen to Health vs. Hype on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts.

00:20:53 - 00:21:36 | Speaker 1:

When Alexander Fleming was working with penicillin at the end of the 1920s, he was mostly approaching it as something that would have uses in a laboratory, such as using it to isolate different cultures from one another, depending on whether they were sensitive to penicillin. One of his students, Cecil George Payne, does seem to have successfully used penicillin to cure eye infections in newborns in 1930, as well as to treat a minor who had an infected scratch on his cornea. But Payne did not publish anything about this success, and he also does not seem to have realized until much later that he had been looking at something that could have revolutionized medicine.

00:21:37 - 00:22:10 | Speaker 2:

Meanwhile, in 1932, German bacteriologist Gerhard Domach was studying a red dye that hadn't been an effective antibacterial in a Petri dish, but turned out to treat strep infections in mice and staph infections in rabbits. This dye was developed into the drug Protonsil, the first sulfa drug, and the first drug used to treat and prevent a range of bacterial infections in humans. Unlike Salverson, which was primarily used to treat syphilis, Protonsil could treat a variety of gram-positive bacteria.

00:22:10 - 00:22:49 | Speaker 1:

Domach was awarded the Nobel Prize in Physiology or Medicine for this work in 1939, but the Nazi Party had forbidden Germans to accept the Nobel Prize. This was because the Nobel Peace Prize had previously been awarded to German pacifist Karl von Ossiecki in 1935. Domach accepted the prize anyway. Afterward, he was arrested by the Gestapo and forced to write to the Nobel Committee, rejecting the prize. He wasn't able to get his medal for having won the Nobel Prize until after the end of World War II, and he never actually got the monetary award.

00:22:50 - 00:23:08 | Speaker 2:

As a side note, we mentioned Paul Ehrlich earlier in the episode. The street in Frankfurt where his institute was located was named after him, but it was renamed after the Nazis came to power because he was Jewish. Ehrlich was no longer living at this point. He had died after a stroke in 1915.

00:23:08 - 00:23:56 | Speaker 1:

So the same year that Domach was awarded the Nobel Prize for developing the first sulfa drug, researchers at the Sir William Dunn School of Pathology at Oxford University started studying penicillin. There had been a Department of Pathology at Oxford for decades, but this school was almost brand new. It had opened in 1935 after the university received funds from the estate of the late Sir William Dunn, which is what funded the new school. Australian pathologist Howard Walter Florey had been appointed professor of pathology and the research team he recruited included Ernst Chain, who was a Jewish biochemist who had fled to the UK from Germany after the Nazi party came to power. Flory, Chain, and others at

00:23:56 - 00:24:22 | Speaker 2:

Oxford had been inspired by Domac's success with sulfa drugs, and in 1938 they started studying the enzyme lysozyme, which Alexander Fleming had discovered. Chain also found Fleming's earlier paper on the antimicrobial effects of penicillium mold, and Oxford already had a sample of Fleming's mold on hand. The team started working with it in 1939. Fleming and his team at St. Mary's had been

00:24:22 - 00:25:00 | Speaker 1:

mostly working with small amounts of mold in a petri dish. Fleury and Shane, on the other hand, were trying to extract enough of the active substance to test whether it could be used as a medicine. Even though they were going to start with mice, which are very small, this required a lot of mold, so much more mold than Fleming had been working with. Hospital bedpans turned out to be just about the right size and shape to grow this mold in, but most of the ones on hand were needed by hospital patients. So the team at Oxford started repurposing what

00:25:00 - 00:25:08 | Speaker 2:

whatever vessels they could scrounge up, jars and food tins, milk churns, fuel cans, all kinds of

00:25:08 - 00:25:42 | Speaker 1:

things. I love that it's a little hodgepodge-y. It's very hodgepodge-y. It was also really a team effort. Over the course of the project, six women were paid two pounds a week to tend to the fermenting mold. They were Ruth Callow, Claire Innot, Betty Cook, Peggy Gardner, Megan Lancaster, and Patricia McKegney, and they were nicknamed the Penicillin Girls. Norman Heatley developed a method to extract penicillin from the mold broth into amyl acetate and then back into water. Edward

00:25:42 - 00:26:15 | Speaker 2:

Abraham developed techniques to purify it. And on May 25th, 1939, almost exactly 10 years after the British Journal of Experimental Pathology received Fleming's paper on penicillin, they conducted an experiment involving eight mice. All eight of the mice were injected with streptococcus bacteria. Then four of the mice were injected with penicillin, and the other four were left untreated. The four untreated mice died, but the other four who got penicillin all survived.

00:26:16 - 00:26:49 | Speaker 1:

Other tests on animals followed, including studies on rats and cats. They tested penicillin's efficacy against multiple bacteria. In addition to strep and staph, there was clostridium septicum, which can cause gas gangrene. And penicillin was dramatically effective against all of them, with little to no toxicity to their test subjects. In August of 1940, Chain, Florey, Heatley, and others published penicillin as a chemotherapeutic agent in the journal The Lancet, detailing the

00:26:49 - 00:27:54 | Speaker 2:

basic findings of their research. It was clear from this work that penicillin could potentially be a life-saving drug for human beings. And at this point, aside from the medicines we have talked about in this episode, there just weren't many effective options to treat bacterial infections. That meant that minor illnesses like strep throat could lead to much more serious problems like rheumatic fever. Life-threatening infections could develop in injuries that had seemed really superficial. People like Ignaz Semmelweis and Joseph Lister had advocated for things like hand-washing and sterile surgical techniques to cut down on the likelihood that a person would contract an infection during childbirth or surgery. But infections could still happen, and often there just was not much that could be done about it. SELFA drugs had been a huge step forward in providing broadly effective treatments for bacterial infections, but a lot of people were allergic to them, and most of them could also cause a range of unpleasant side effects.

00:27:54 - 00:28:43 | Speaker 1:

So figuring out whether penicillin could be a usable drug in people and not just small mammals was a huge priority. And since people are significantly bigger than mice, that meant that the team needed to grow a lot more mold. But at this point, the U.K. was at war. Germany had invaded Poland on September 1st, 1939, and both the U.K. and France had declared war on Germany two days later. That meant that a lot of equipment and materials were now dedicated to the war effort. For the sake of time and expense, Norman Heatley designed a flat rectangular pottery vessel with a spout that was stackable and glazed on the inside to make it watertight. The team eventually used 700 of these vessels to produce about 500 liters of mold broth every week.

00:28:44 - 00:29:10 | Speaker 2:

But this was a slow and cumbersome and kind of fiddly process. Even with all 700 vessels in use, it took about four weeks to make enough penicillin to treat one human patient. And it took months for all 700 of those vessels to be ready. At the end of 1940, only about 90 of them were all set and had been seeded with mold spores.

00:29:10 - 00:29:45 | Speaker 1:

The first attempt to treat a person with penicillin made from all of this mold started on February 12, 1941. That patient was Albert Alexander, and there are multiple conflicting descriptions of how he became injured. In some accounts, he cut himself shaving. In others, he scratched himself while pruning roses. In still others, he was injured in a bombing during the Blitz. But regardless of the cause, it is documented that he had a very serious infection that was certain to be fatal if left untreated.

00:29:46 - 00:30:00 | Speaker 2:

Alexander showed promising signs of recovery within 24 hours of being treated with penicillin. But because so little penicillin had been made at this point, they had to collect his urine and extract the penicillin.

00:30:00 - 00:30:27 | Speaker 3:

penicillin out of it and then reuse it. So the body excretes penicillin really rapidly and roughly 70% of it comes out in the urine unchanged. It could be more or less than that. I saw numbers that were literally from 1% to 99%. It's possible to recover half or more of that excreted penicillin using the same basic method that was used to extract it from the mold broth in the first place.

00:30:28 - 00:30:46 | Speaker 2:

Even with the penicillin that had been reclaimed from his urine, there wasn't enough to totally cure Alexander's infection. Eventually, the team had given him all of the penicillin they had, and after they ran out, his infection returned. He died on March 15, 1941.

00:30:47 - 00:31:23 | Speaker 3:

So it was clear that making enough penicillin to do a clinical trial was going to be a huge challenge. And with all this effort, they had not made enough to successfully treat even one patient. Although focusing on treating children would have allowed the team to use smaller doses, at this point, the priority was really confirming that penicillin worked in adults. And then if it did, supplying allied troops with it. Infections were a major, major cause of death for wounded soldiers. and effective treatments for bacterial illnesses could also allow sick soldiers to return to duty

00:31:23 - 00:31:47 | Speaker 2:

faster. But the prospects for doing that in the UK were grim. Although there were British companies that were interested in working with penicillin, most were dedicated to critical wartime work involving drugs and other chemicals that were already known to have a use. Plus, British factories were at risk of being bombed or otherwise attacked. Flory and his team also

00:31:47 - 00:32:20 | Speaker 3:

understood that if Britain were invaded, they might need to destroy their research work to prevent it from being captured by the Germans. But they were also really unwilling to risk losing their penicillium mold entirely. Norman Heatley suggested that several of them intentionally rub mold into their coats so that if they had to flee, they could just wear their samples with them undetected. Why does everybody on this transport smell weird?

00:32:21 - 00:32:43 | Speaker 2:

Smells a little musty. In 1941, Florey and Heatley went to the United States to try to find pharmaceutical companies that could help. Work in the UK didn't stop at this point or in other countries that had started experimenting with penicillium, but the focus on mass-producing penicillin shifted to the U.S. And we'll talk more about that after a sponsor break.

00:32:46 - 00:33:15 | Speaker 1:

Busy morning or a slow-sip latte kind of day? Whatever your morning calls for, the new Nespresso Virtual Up Machine makes the perfect cup. Latte, iced coffee, bold espresso. Explore a world of coffees with one-button press. Enjoy effortless mornings made entirely your way with Nespresso Virtuo Up. New Virtuo Up. Press to explore. Shop now at Nespresso.com.

00:33:17 - 00:36:13 | Speaker 2:

Living with a rare autoimmune condition can bring a lot of uncertainty, but it can also bring people together in powerful ways. Tune in for season six of Untold Stories, Life with a Severe Autoimmune Condition, a Ruby Studio production in partnership with Argenix. This season, host Martine Hackett brings you fresh stories from people living with MG and CIDP and expands the conversation to people living with other rare conditions like myositis and IGAM. Through their stories, you'll learn what it's like to participate in clinical trials seeking new treatments, how connection fuels hope, and how people can support one another along the way. Because living with a rare disease isn't about getting through it, it's about moving forward together. Listen to Untold Stories, Life with a Severe Autoimmune Condition on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts. all righty there is excited and then there is vacation excited and we are vacation excited right now because we have a trip planned to Baja Mar in Nassau to be honest I'm kind of mentally already checked in and I have a beautiful drink in my hand what I love about this is that you can do it your way there are three luxury hotels all in one place the refined rosewood the playfully hip SLS or the stylish Grand Hyatt. So no matter what your vibe is, if it's relaxed, if it's glam, if it's kind of somewhere in between, you're covered. And then there is everything else. This is like an embarrassment of options. There are more than 45 restaurants, bars and lounges, incredible chefs, incredible drinks. I'm going to be all over that. There is a lot of great nightlife that you can get into. like the John Baptiste Jazz Club, which I am also very excited about. If you are a family going to visit, there's a 15-acre water park. And what I am also excited about, shark and sea turtle encounters. Bring them on and don't even get me started about the Daily Flamingo Parade. If you're into sporty stuff, all there. There is a golf course, tennis, pickleball, anything you can think of. Tracy's gonna spend a lot of time at the spa and we are gonna spend a lot of time enjoying ourselves. There's excited and then there is Baja Mar vacation excited. Start planning your perfect getaway at bahamar.com. We've all done it. Tumble down an internet rabbit hole trying to self-diagnose. And sometimes doing our own research can leave us more anxious than informed. Your feed is packed with wellness trends telling you to cold plunge, protein max, detox, track your sleep. But what's actually real? What's exaggerated? What's just wrong? That's exactly what Health vs. Hype from the American Medical Association and iHeartMedia's Ruby Studio is here to find out. Each episode, Emmy-nominated science communicator Trace Dominguez, who's racked up billions of views across PBS, Discovery Channel, and YouTube,

00:36:13 - 00:36:34 | Speaker 2:

talks to doctors, influencers, and real people trying these trends. Not to cancel them, not to hype them more, but to actually understand them. Because when it comes to your health, who you listen to matters. Start asking better questions and listen to Help vs. Hype on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts.

00:36:44 - 00:37:22 | Speaker 1:

In June of 1941, Howard Florey and Norman Heatley took a series of flights to get from the UK to the US. These flights were paid for by the Rockefeller Foundation, which had also done some of the funding for their research. When they left, they had treated a total of six patients with penicillin. In addition to Albert Alexander, one other patient had died. But that patient died of a ruptured aneurysm, not of the infection that the penicillin was treating. There was just not enough penicillin to treat more people than that.

00:37:23 - 00:38:01 | Speaker 2:

As Florey and Heatley were preparing to go, the Oxford team was preparing and freeze-drying as much penicillin as possible for them to take with them. Florey was also finishing a second paper titled Further Observations on Penicillin, which went on to be published that August. There had been a lot of debate about whether to publish this paper. On the one hand, it contained a lot of information that could save people's lives. But on the other hand, there were concerns about Germany or its allies producing penicillin, which could provide them with an advantage in the war. And that paper would give them a lot more information to do it.

00:38:01 - 00:39:01 | Speaker 1:

There were similar debates among the Oxford team about whether to patent penicillin. A lot of them found the idea of patenting any medicine to be just appalling. while Ernst Chain argued that penicillin was their work and it deserved to be protected. Chain also thought that their ongoing struggles to get enough funding for their work would be totally resolved if it could just be paid for through licensing fees from a patent. Chain was also deeply disappointed by not being part of this trip to the United States and this is something that seems to have caused a huge rift between him and Flory. since the whole purpose of this trip was to try to get manufacturing started and Heatley was the person who had been focused on manufacturing. Like, it makes sense that Heatley would be the person to go. They also wanted to minimize the number of people going for the sake of secrecy. This decision made sense, but Chain seems to have been incredibly upset by it.

00:39:01 - 00:39:34 | Speaker 2:

The U.S. had passed the Lend-Lease Act in March of 1941, which established a framework for the United States to provide the Allies with things like weapons, vehicles, materials, machinery, and facilities that would promote the defense of the United States. The manufacture of penicillin seemed to fall under that definition, but Florey and Heatley still had to find a pharmaceutical company that had the interest and the ability to try to produce penicillin on a commercial scale. They had a series of meetings

00:39:34 - 00:39:59 | Speaker 1:

and disappointments and kind of stops and starts, and then Florey and Heatley wound up at the Department of Agriculture's Northern Regional Research Laboratory, or NRRL, in Peoria, Illinois, which already had a fermentation division, which was very handy since they grew penicillin by fermenting. Researchers there started working on finding ways to grow penicillin mold a lot.

00:40:00 - 00:40:07 | Speaker 2:

faster than it had been. They started on that work in July of 1941. This was a multi-step process.

00:40:07 - 00:40:32 | Speaker 1:

At Oxford, researchers had been growing the mold in a broth in flat rectangular pottery vessels. In Illinois, researchers figured out that growing it in corn-steep liquor yielded about 10 times more penicillin. This was convenient because corn-steep liquor is a byproduct of the wet milling process and people were already trying to find a practical use for it. Those vessels in

00:40:32 - 00:41:42 | Speaker 2:

Oxford were also rectangular and flat because the mold was essentially growing as a flat surface layer and researchers in Peoria thought it would be more efficient to grow the mold in a submerged medium. But this also required their finding a different strain of penicillium mold that would grow really well while submerged and also produce the antimicrobial substance that they need because not all of the penicillium strains really did that very well. This involved gathering mold from all over the world, which they did with the help of the Army Transportation Corps, and they tested all these samples in the lab. They eventually, though, found a sample growing on a moldy cantaloupe that worked really well. This find is usually credited to lab assistant Mary Kay Hunt, who was nicknamed Moldy Mary. She had found this cantaloupe not in some far-reaching place brought back by the Army Transportation Corps, but at a local Peoria fruit market. This strain of the mold, Penicillium chrysogenum, was about a hundred times more productive than the other strains they tried.

00:41:43 - 00:42:21 | Speaker 1:

Even as the research lab figured out ways to increase the yield of penicillium mold, they still needed pharmaceutical or chemical manufacturers to actually get a penicillin drug into production. A group of pharmaceutical companies and the federal government met in October of 1941 to coordinate both the production process and information sharing. The goal was to first produce enough penicillin for clinical trials and then, if those were successful, to scale up production to make as much as could be needed for Allied troops. This was a huge and really unprecedented level of cooperation.

00:42:21 - 00:43:12 | Speaker 2:

It was also going to be really tricky. John L. Smith from Pfizer had this to say about it, quote, the mold is as temperamental as an opera singer. The yields are low, the isolation is difficult, the extraction is murder, the purification invites disaster, and the assay is unsatisfactory. So the Office of Science Research and Development helped coordinate information sharing about methods and techniques to do this successfully, along with managing 57 different research contracts related to it. The War Production Board also worked with 25 different companies to scale up production of penicillin. They narrowed it down to those 25 after investigating more than 175 different companies to determine whether they were suitable or not.

00:43:13 - 00:43:32 | Speaker 1:

The first patient in the U.S. to be treated with penicillin was 33-year-old Ann Miller, who had developed septicemia after a pregnancy loss. Her treatment started on March 14, 1942, and it required half the penicillin that was in existence in the U.S. at that point.

00:43:32 - 00:44:17 | Speaker 2:

Also in 1942, back in the U.K., Alexander Fleming got some penicillin from the Oxford group, which was still at work, used that to treat one of his patients. And when that treatment was successful, he got a huge write-up about it in the Times. This article didn't actually mention Flory or any of the other researchers at the Oxford team, though, and this really started to build the perception that penicillin was solely Fleming's work. Fleming also seemed willing to take that credit, and Flory didn't want to talk to the press and also didn't want the rest of the Oxford team to talk to the press. So it's really starting the ball rolling on this being just Alexander Fleming's

00:44:17 - 00:45:05 | Speaker 1:

own work and nobody else's. The fact that all of this was happening during World War II came along with a number of ethical dilemmas. One that we referenced earlier was how careful researchers should be about making sure information about penicillin and penicillin production wasn't available to Germany or its allies. Doctors and medical ethicists generally agreed that if a patient needed penicillin and the penicillin was available, they could have it, regardless of their nationality or what army they fought for. But since access to penicillin could also create a military advantage people also believe that information about how to make it or samples of the mold itself should not be shared, not with Germany and not with any countries likely

00:45:05 - 00:46:05 | Speaker 2:

to cooperate with Germany. There are a lot of articles discussing whether, in fact, somebody in Germany did or did not receive one of Fleming's samples way earlier in this whole story before the hostilities started. Within the U.S., another ethical issue was access to penicillin because once clinical trials were complete, the penicillin being produced was going to be reserved almost exclusively for military use. At the same time, there were definitely going to be civilians whose lives would be lost without it. Dr. Chester Kiefer was responsible for rationing penicillin to civilians and was absolutely inundated with requests for it. This led some people to figure out ways to make their own penicillin. For example, on November 10th, 1943, Julius A. Vogel, who was the plant physician at a steel plant in Pennsylvania, figured out how to make penicillin

00:46:05 - 00:47:10 | Speaker 1:

in his kitchen. See, my plan as a kid was not completely off the rails because I had the knowledge of a plant physician. Vogel based his work on an earlier discovery by George Robinson and James Wallace at Singer Laboratory at Allegheny General Hospital in Pittsburgh, Pennsylvania. On October 8, 1943, they reported that they had found a way to make a topical treatment by soaking a gauze pad in penicillium mold and then letting it grow in a Petri dish for four or five days. Vogel, who had been disabled following a serious infection in his knee as a child, built on this to turn his kitchen into a miniature factory for treating similarly mold-infused gauze. Vogel's wife Eunice was a big part of this process, making the auger for the petri dishes and sterilizing the equipment between batches. As you can imagine, all of this required a lot of careful planning to keep a steady supply of mold that was the right age to produce penicillin.

00:47:10 - 00:48:02 | Speaker 2:

Yeah, Vogel talked a lot about how if penicillin had existed when he was a child, he probably would not have almost died and then had like a disability that affected him for the rest of his life. Vogel presented his development at the Department of Industrial Research on November 11th, 1943, and he got a lot of criticism from the research community and from the companies that were working on mass producing penicillin. There were some understandable concerns about the potential for penicillin made at home to be contaminated in some way, but Vogel reportedly used these gauze pads at steel mills all over the area, treating workers who had on-the-job accidents and otherwise would have just not had access to any antibiotics at all.

00:48:02 - 00:48:49 | Speaker 1:

Yet another ethical conundrum arose after Florey and Chain traveled to northern Africa in 1943, to test penicillin on wounded soldiers and realized that it was also effective against gonorrhea. Before this point, penicillin had been envisioned as something that would save the lives of soldiers who had been seriously injured in battle or had contracted a serious illness like bacterial pneumonia. But gonorrhea, especially in its early stages, is more of a nuisance. Winston Churchill reportedly said that penicillin should be used for the, quote, best military advantage, which meant when supplies were limited, getting soldiers who had gonorrhea back into peak condition rather than treating seriously injured soldiers who were going to be

00:48:49 - 00:49:31 | Speaker 2:

sent back home. Most supplies were not limited for that much longer, though. Pfizer's first plant for the commercial production of penicillin opened in Brooklyn, New York on March 1st, 1944. By that point, clinical trials had showed that penicillin was clearly beneficial against a range of pathogenic bacteria. Refinements to the production process and to the mold itself, using things like x-rays and UV light, continued to increase the yield. Meanwhile, Alexander Fleming, who wasn't involved with any of this, was on the cover of Time magazine on May 15th of 1944. By this point,

00:49:31 - 00:50:06 | Speaker 1:

pharmaceutical companies in the U.S. were trying to produce enough penicillin to meet the needs of the D-Day invasion. Propaganda posters were hung on the walls of penicillin factories, reminding workers that they were doing it for the troops. And production of penicillin in the U.S. expanded rapidly. 21 billion units of the drug had been made in 1943, and in 1945, it had jumped to 6.8 trillion. In March of 1945, the U.S. was able to lift rationing restrictions on penicillin and make

00:50:06 - 00:51:06 | Speaker 2:

it commercially available to the public. After the liberation of Paris in 1944, American military hospitals throughout France started trying to extend the supply of penicillin in the country, which is what inspired this episode. The French military penicillin team was established, and starting in January of 1945, the team collected urine from patients to reclaim the penicillin in it. So if a patient was being treated with penicillin, their bed was marked with a placard to note that their urine should be collected. Patients who were well enough to get up and go to the bathroom themselves were instructed to urinate in flasks that were just left around the wards for that purpose. Officials were understandably a little concerned that these flasks that people were peeing into could themselves become a source of infection, so the penicillin team collected them all twice a day. After the war, manufacturing methods for

00:51:06 - 00:51:34 | Speaker 1:

penicillin that had been developed in the U.S. were introduced in the U.K., which meant that the same researchers who had originally developed the drug had to pay licensing fees to access American methods to produce it. Although penicillin itself had not been patented, some of the manufacturing methods had been. New penicillin factories were also established around the world as nations started making their own supply or expanded production from research

00:51:34 - 00:51:57 | Speaker 2:

that they had been doing as the war was going on. Alexander Fleming, Ernst Boris Chain, and Howard Walter Florey were jointly awarded the Nobel Prize in Physiology or Medicine in 1945. That same year, the chemical structure of penicillin was confirmed by Dorothy Crowfoot Hodgkin, and that paved the way for synthetic forms of penicillin.

00:51:58 - 00:52:16 | Speaker 1:

Penicillin's effect on medicine was massive, and many other antibiotics followed. Streptomycin, which was the first truly effective treatment for tuberculosis, was developed in 1943. We have covered that and the controversy around who should be credited with discovering it on the podcast in 2013.

00:52:16 - 00:53:02 | Speaker 2:

This is an enormous advance in medicine, but by the 1950s, some bacteria were already becoming resistant to penicillin, including some strains of staph bacteria, and this was something that Fleming had foreseen, and he warned about it in his Nobel Prize address. Quote, it is not difficult to make microbes resistant to penicillin in the laboratory by exposing them of concentrations not sufficient to kill them, and the same thing has occasionally happened in the body. The time may come when penicillin can be bought by anyone in the shops. Then there is the danger that the ignorant man may easily underdose himself and by exposing his microbes to non-lethal

00:53:02 - 00:53:38 | Speaker 1:

quantities of the drug make them resistant. This is obviously still a problem. You've probably heard about it in your day-to-day life at some point. And it's compounded by the fact that most antibiotics in use today were developed between the 1940s and the 1960s, along with the widespread use of antibiotics in agriculture. In 2014, the World Health Organization warned that the world is nearing the point of a post-antibiotic era and currently describes antibiotic resistance as one of the biggest threats to global health, food security, and development.

00:53:39 - 00:53:48 | Speaker 2:

Yeah, the use of penicillin and other antibiotics after the discovery and sort of the golden age of antibiotics could be a whole other episode.

00:53:48 - 00:53:50 | Speaker 1:

We're living through it.

00:53:55 - 00:54:10 | Speaker 2:

Thanks so much for joining us on this Saturday. If you'd like to send us a note, our email address is historypodcast at iheartradio.com. And you can subscribe to the show on the iHeartRadio app, Apple Podcasts, or wherever you listen to your favorite shows.

00:54:16 - 00:55:19 | Speaker 1:

Living with a rare autoimmune condition brings uncertainty, but it can also create community. In Season 6 of Untold Stories, Life with a Severe Autoimmune Condition, they go beyond MG and CIDP, as host Martine Hackett welcomes stories from other conditions like myositis and iGan into the conversation. Untold Stories is produced by Ruby Studio in partnership with Argenix. Listen to Untold Stories, life with a severe autoimmune condition on the iHeartRadio app, Apple Podcasts, or wherever you get your podcasts. Hey, everybody, we are getting ready to go on a trip. We're not packed yet, but our brains definitely are because we have a trip to Baja Mar on the horizon and it's kind of all I can think about. I'm so excited about the food. There are amazing restaurants. the lounge is there that I'm going to sample everything I possibly can. I'm going to gaze into the water and mostly I am going to watch the daily flamingo parade, which might be the thing I'm most excited about. There's also an incredible spa and I know Tracy's going to be taking advantage of that. There is excited and then there is Bahamar excited. Start planning at bahamar.com.

00:55:19 - 00:55:34 | Speaker 3:

Snoring, gasping for air during sleep, daytime sleepiness. I'm Shaquille O'Neal and this shouldn't be anybody's experience. Ask your doctor about Zep Bound towards Epitide. The first and only FDA-approved prescription medicine for moderate to severe obstructive sleep apnea in adults with obesity.

00:55:35 - 00:56:42 | Speaker 2:

ZepBound is a prescription medicine used with a reduced-calorie diet and increased physical activity to help adults with moderate to severe obstructive sleep apnea, OSA, and obesity to improve their OSA. ZepBound is approved as a 2.5, 5, 7.5, 10, 12.5, or 15 milligram injection. ZepBound contains trisepatide and should not be used with other trisepatide-containing products or any GLP-1 receptor agonist medicines. It is not known if ZepBound is safe and effective for use in children. Don't share needles or pens or reuse needles. Don't take if allergic to it, or if you or someone in your family had medullary thyroid cancer, or if you've had multiple endocrine neoplasia syndrome type 2. Tell your doctor if you get a lump or swelling in your neck. Stop ZepBound and call your doctor if you have severe stomach pain or a serious allergic reaction. Severe side effects may include inflamed pancreas or gallbladder problems. Tell your doctor if you experience vision changes before scheduled procedures with anesthesia. If you're nursing, pregnant, plan-to-be, or taking birth control pills, taking ZepBound with a sulfonylurea or insulin may cause low blood sugar. Side effects include nausea, diarrhea, and vomiting, which can cause dehydration and worsen kidney problems.

00:56:42 - 00:56:49 | Speaker 3:

Talk to your doctor. Call 1-800-545-5979 or visit ZepBound.lily.com.

00:56:49 - 00:56:51 | Speaker 1:

Mom, are we there yet?

00:56:51 - 00:56:52 | Speaker 4:

Ten more minutes

00:56:52 - 00:56:54 | Speaker 1:

Only ten minutes? Can you drive slower?

00:56:54 - 00:57:15 | Speaker 4:

What's up with them today? Lingo Kids That app we downloaded last week? They love it The games Oh, this funny baby bot character Kids, we're almost there No! With more than 4,000 interactive games, songs, and shows little ones can't get enough of Lingo Kids is the number one entertainment platform for young kids Why didn't we download this sooner?

00:57:16 - 00:57:17 | Unknown:

Lingo Kids

00:57:17 - 00:57:23 | Speaker 4:

Everything kids love Download it for free. This is an iHeart Podcast. Guaranteed human.

0/0